Jeffrey Gelfand, MD
Professor
Neurology
School of Medicine

Dr. Gelfand received an A.B. in history from Princeton University, graduating summa cum laude and Phi Beta Kappa. He received his M.D. from Harvard Medical School. He completed an internship in internal medicine, residency in neurology, and subspecialty fellowship training in MS/neuroimmunology, all at UCSF. Dr. Gelfand went on to earn a Masters in Advanced Study in clinical research at UCSF. He is board-certified in Neurology.

Dr. Gelfand serves as Medical Director of the UCSF MS and Neuroinflammation Clinic. Dr. Gelfand is also the clinical director of the UCSF Center for Encephalitis and Meningitis (CEM). He is a Coach medical educator in the UCSF Medical School Bridges curriculum. Dr. Gelfand is a recipient of the Robert B. Layzer teaching award (2014), which is voted on annually by UCSF Neurology Department residents; an Excellence in Teaching Award from the UCSF Haile T. Debas Academy of Medical Educators (2015); and was inducted into the UCSF Haile T. Debas Academy of Medical Educators (2020). He served as the Program Director of the UCSF MS Center Clinical Fellowship Training Program for a decade (through 2023), helping to train a new generation of specialists in the field.

Dr. Gelfand is a Fellow of the American Academy of Neurology (FAAN). In 2023 he was elected Chair of the American Academy of Neurology Autoimmune Neurology section.

• Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.
  JAMA neurology 2024 Cross AH, Gelfand JM, Thebault S, Bennett JL, von Büdingen HC, Cameron B, Carruthers R, Edwards K, Fallis R, Gerstein R, Giacomini PS, Greenberg B, Hafler DA, Ionete C, Kaunzner UW, Kodama L, Lock C, …
• Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis.
  Molecular pharmacology 2024 Perez-Paramo YX, Dufield D, Veeramachaneni R, Parkhurst E, Harp C, Ramesh A, Winger RC, Cross AH, Gelfand JM, Bar-Or A, Mathews WR, Anania VG
• A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack.
  JMIR human factors 2024 Block VJ, Koshal K, Wijangco J, Miller N, Sara N, Henderson K, Reihm J, Gopal A, Mohan SD, Gelfand JM, Guo CY, Oommen L, Nylander A, Rowson JA, Brown E, Sanders S, Rankin K, Lyles CR, Sim I, Bove R
• "Self-care selfies": Patient-uploaded videos capture meaningful changes in dexterity over 6 months.
  Annals of clinical and translational neurology 2023 Gopal A, Torres WO, Winawer I, Poole S, Balan A, Stuart HS, Fritz NE, Gelfand JM, Allen DD, Bove R
• Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.
  Annals of neurology 2023 Bartley CM, Ngo TT, Do LD, Zekeridou A, Dandekar R, Muñiz-Castrillo S, Alvarenga BD, Zorn KC, Tubati A, Pinto AL, Browne WD, Hullett PW, Terrelonge M, Schubert RD, Piquet AL, Yang B, Montalvo M, Kung …
• Fall Assessment and Monitoring in People With Multiple Sclerosis: A Practical Evidence-Based Review for Clinicians.
  Neurology. Clinical practice 2023 Gopal A, Gelfand JM, Bove R, Block VJ
• Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression.
  JAMA neurology 2023 McEntire CRS, Fletcher A, Toledano M, Epstein S, White E, Tan CS, Mao-Draayer Y, Banks SA, Aksamit AJ, Gelfand JM, Thakur KT, Anand P, Cortese I, Bhattacharyya S
• A Predictive Autoantibody Signature in Multiple Sclerosis.
  medRxiv : the preprint server for health sciences 2023 Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C, Gerungan C, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, …
• Association of Daily Physical Activity with Cervical Spinal Cord Areas in Multiple Sclerosis.
  Multiple Sclerosis and Related Disorders 2023 Valerie J Block, Shuiting Cheng, Jeremy Juwono, Richard Cuneo, Gina Kirkish, Amber M Alexander, Mahir Khan, Amit Akula, Eduardo Caverzasi, Nico Papinutto, William A Stern, San Francisco MS-EPIC Team …
• Autoimmune Encephalitis Consensus Criteria: Lessons Learned From Real-World Practice.
  Neurology. Clinical practice 2023 Gelfand JM, Guo CY
• Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report.
  Frontiers in neurology 2023 Bartley CM, Ngo TT, Cadwell CR, Harroud A, Schubert RD, Alvarenga BD, Hawes IA, Zorn KC, Hunyh T, Teliska LH, Kung AF, Shah S, Gelfand JM, Chow FC, Rasband MN, Dubey D, Pittock SJ, DeRisi JL, Wilson …
• Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
  Proceedings of the National Academy of Sciences of the United States of America 2023 Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen HC, Carruthers R, Edwards KR, Fallis R, Giacomini PS, Greenberg BM, Hafler DA, Ionete C, Kaunzner UW, …
• Autoimmune Encephalitis Misdiagnosis in Adults.
  JAMA neurology 2023 Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A…
• Remote Observational Research for Multiple Sclerosis: A Natural Experiment.
  Neurology(R) neuroimmunology & neuroinflammation 2022 Bove R, Poole S, Cuneo R, Gupta S, Sabatino J, Harms M, Cooper T, Rowles W, Miller N, Gomez R, Lincoln R, McPolin K, Powers K, Santaniello A, Renschen A, Bevan CJ, Gelfand JM, Goodin DS, Guo CY, Romeo…
• Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2022 Block VJ, Cheng S, Juwono J, Cuneo R, Kirkish G, Alexander AM, Khan M, Akula A, Caverzasi E, Papinutto N, Stern WA, Pletcher MJ, Marcus GM, Olgin JE, Hauser SL, Gelfand JM, Bove R, Cree BA, Henry RG
• Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course.
  Cell 2022 iMSMS Consortium. Electronic address: sergio.baranzini@ucsf.edu, iMSMS Consortium
• Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis.
  Journal of neurology, neurosurgery, and psychiatry 2022 Abdelhak A, Cordano C, Boscardin WJ, Caverzasi E, Kuhle J, Chan B, Gelfand JM, Yiu HH, Oertel FC, Beaudry-Richard A, Condor Montes S, Oksenberg JR, Lario Lago A, Boxer A, Rojas-Martinez JC, Elahi FM, …
• Making Every Step Count: Minute-by-Minute Characterization of Step Counts Augments Remote Activity Monitoring in People With Multiple Sclerosis.
  Frontiers in neurology 2022 Block VJ, Waliman M, Xie Z, Akula A, Bove R, Pletcher MJ, Marcus GM, Olgin JE, Cree BAC, Gelfand JM, Henry RG
• Transitioning From S1P Receptor Modulators to B Cell-Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data.
  Neurology(R) neuroimmunology & neuroinflammation 2022 Rowles WM, Hsu WY, McPolin K, Li A, Merrill S, Guo CY, Green AJ, Gelfand JM, Bove RM
• A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial.
  Multiple sclerosis and related disorders 2022 Bove R, Anderson A, Rowles W, Rankin KA, Hills NK, Carleton M, Cooper J, Cree BAC, Gelfand JM, Graves JS, Henry RG, Krysko KM, Rush G, Zamvil SS, Joffe H, Chan JR, Green AJ
• Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis.
  Neurology(R) neuroimmunology & neuroinflammation 2022 Peris Sempere V, Muñiz-Castrillo S, Ambati A, Binks S, Pinto AL, Rogemond V, Pittock SJ, Dubey D, Geschwind MD, Gelfand JM, Dilwali S, Lee ST, Knight J, Elliott KS, Irani S, Honnorat J, Mignot E
• Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
  Annals of neurology 2022 Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono …
• Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.
  JAMA neurology 2021 Gu W, Rauschecker AM, Hsu E, Zorn KC, Sucu Y, Federman S, Gopez A, Arevalo S, Sample HA, Talevich E, Nguyen ED, Gottschall M, Nourbakhsh B, Gold CA, Cree BAC, Douglas VC, Richie MB, Shah MP, Josephson…
• ANA Investigates Therapeutic Advancements in Neuroimmunology.
  Annals of neurology 2021 Samudralwar RD, Goss AL, Richie M, Gelfand JM
• Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment.
  Neurology(R) neuroimmunology & neuroinflammation 2021 Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM
• Glucocorticoids for therapeutic immunosuppression: Clinical pearls for the practicing neurologist.
  Journal of the neurological sciences 2021 Galati A, Brown ES, Bove R, Vaidya A, Gelfand J
• Identifying falls remotely in people with multiple sclerosis.
  Journal of neurology 2021 Block VJ, Pitsch EA, Gopal A, Zhao C, Pletcher MJ, Marcus GM, Olgin JE, Hollenbach J, Bove R, Cree BAC, Gelfand JM
• Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.
  Neurology. Clinical practice 2021 Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE
• Foundational Telemedicine Workshop for First-Year Medical Students Developed During a Pandemic.
  MedEdPORTAL : the journal of teaching and learning resources 2021 Cornes S, Gelfand JM, Calton B
• Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.
  Journal for immunotherapy of cancer 2021 Guidon AC, Burton LB, Chwalisz BK, Hillis J, Schaller TH, Amato AA, Betof Warner A, Brastianos PK, Cho TA, Clardy SL, Cohen JV, Dietrich J, Dougan M, Doughty CT, Dubey D, Gelfand JM, Guptill JT, …
• Effects of COVID-19 "Sheltering in Place" on Activity in People With Multiple Sclerosis.
  Neurology. Clinical practice 2021 Block VJ, Bove R, Gelfand JM, Cree BAC
• Tumour necrosis factor inhibitor monotherapy for CNS neurosarcoidosis.
  Journal of neurology, neurosurgery, and psychiatry 2021 Gelfand JM
• UpToDate
  Manifestations of systemic lupus erythematosus affecting the peripheral nervous system. 2021 Jeffrey M. Gelfand, Jinoos Yazdany.
• UpToDate
  Neurologic and neuropsychiatric manifestations of systemic lupus erythematosus. 2021 Jeffrey M. Gelfand, Jinoos Yazdany.
• CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot study.
  Multiple sclerosis journal - experimental, translational and clinical 2021 Block VJ, Gopal A, Rowles W, -Yueh C, Gelfand JM, Bove R
• Underutilization of physical therapy for symptomatic women with MS during and following pregnancy.
  Multiple sclerosis and related disorders 2020 Block VJ, Mestas O, Anderson A, Singh J, Wylie L, Guo CY, Green AJ, Gelfand JM, Bove R
• An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2020 Romeo AR, Rowles WM, Schleimer ES, Barba P, Hsu WY, Gomez R, Santaniello A, Zhao C, Pearce JR, Jones JB, Cree BC, Hauser SL, Gelfand JM, Stewart WF, Goodin DS, Bove RM
• Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis.
  Science immunology 2020 Pröbstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A, Dandekar R, Greenfield AL, Schubert RD, Bisanz JE, Vistnes S, Khaleghi K, Landefeld J, Kirkish …
• Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration?
  Annals of neurology 2020 Cordano C, Yiu HH, Oertel FC, University of California, San Francisco MS-EPIC Team, Gelfand JM, Hauser SL, Cree BAC, Green AJ
• A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.
  Proceedings of the National Academy of Sciences of the United States of America 2020 Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D, University of California, San Francisco MS-EPIC Team, Guo CY,…
• Imaging correlates of visual function in multiple sclerosis.
  PloS one 2020 Caverzasi E, Cordano C, Zhu AH, Zhao C, Bischof A, Kirkish G, Bennett DJ, Devereux M, Baker N, Inman J, Yiu HH, Papinutto N, Gelfand JM, Cree BAC, Hauser SL, Henry RG, Green AJ
• Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment.
  JAMA neurology 2020 Gelfand JM, Yazdany J
• A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development.
  Journal of medical Internet research 2020 Schleimer E, Pearce J, Barnecut A, Rowles W, Lizee A, Klein A, Block VJ, Santaniello A, Renschen A, Gomez R, Keshavan A, Gelfand JM, Henry RG, Hauser SL, Bove R
• Anti-gamma-aminobutyric acid receptor type A encephalitis: a review.
  Current opinion in neurology 2020 Guo CY, Gelfand JM, Geschwind MD
• Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2020 Sheehy CK, Bensinger ES, Romeo A, Rani L, Stepien-Bernabe N, Shi B, Helft Z, Putnam N, Cordano C, Gelfand JM, Bove R, Stevenson SB, Green AJ
• Intrathecal B-cell activation in LGI1 antibody encephalitis.
  Neurology(R) neuroimmunology & neuroinflammation 2020 Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Büdingen HC
• Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia.
  Brain : a journal of neurology 2020 Gelfand JM, Greenfield AL, Barkovich M, Mendelsohn BA, Van Haren K, Hess CP, Mannis GN
• Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis.
  PloS one 2020 Fulton BD, Proudman DG, Sample HA, Gelfand JM, Chiu CY, DeRisi JL, Wilson MR
• Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis.
  Multiple sclerosis journal - experimental, translational and clinical 2019 Block VJ, Zhao C, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Henry R, Gelfand JM, Cree BA
• Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man.
  JAMA neurology 2019 Gupta S, Damon L, Gelfand JM
• Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis.
  Neurology 2019 Mandel-Brehm C, Retallack H, Knudsen GM, Yamana A, Hajj-Ali RA, Calabrese LH, Tihan T, Sample HA, Zorn KC, Gorman MP, Madan Cohen J, Sreih AG, Marcus JF, Josephson SA, Douglas VC, Gelfand JM, Wilson …
• Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.
  The New England journal of medicine 2019 Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, …
• Multiple sclerosis and sarcoidosis: A case for coexistence.
  Neurology. Clinical practice 2019 Tyshkov C, Pawate S, Bradshaw MJ, Kimbrough DJ, Chitnis T, Gelfand JM, Ryerson LZ, Kister I
• GABAA receptor autoimmunity: A multicenter experience.
  Neurology(R) neuroimmunology & neuroinflammation 2019 O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A
• Silent progression in disease activity-free relapsing multiple sclerosis.
  Annals of neurology 2019 University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS,…
• Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.
  JAMA network open 2019 Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM
• pRNFL as a marker of disability worsening in the medium/long term in patients with MS.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ
• Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.
  JAMA neurology 2018 Stern BJ, Royal W, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP
• A young man with numbness in arms and legs: From the National Multiple Sclerosis Society Case Conference Proceedings.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Romeo AR, Lisak RP, Meltzer E, Fox EJ, Melamed E, Lucas A, Freeman L, Frohman TC, Costello K, Zamvil SS, Frohman EM, Gelfand JM
• Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Bove R, Garcha P, Bevan CJ, Crabtree-Hartman E, Green AJ, Gelfand JM
• Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2018 Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM
• Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing.
  JAMA neurology 2018 Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, …
• Distinct HLA associations of LGI1 and CASPR2-antibody diseases.
  Brain : a journal of neurology 2018 Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR
• Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis.
  The Lancet. Neurology 2018 Gelfand JM
• Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment.
  Annals of neurology 2018 Ward ME, Gelfand JM, Lui LY, Ou Y, Green AJ, Stone K, Pedula KL, Cummings SR, Yaffe K
• Migraine is common in patients with sarcoidosis.
  Cephalalgia : an international journal of headache 2018 Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LL
• Sleep disturbance and symptom burden in sarcoidosis.
  Respiratory medicine 2018 Benn BS, Lehman Z, Kidd SA, Miaskowski C, Sunwoo BY, Ho M, Sun S, Ramstein J, Gelfand JM, Koth LL
• Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R
• The state of clinical research in neurology.
  Neurology 2018 Hall DA, Ramos AR, Gelfand JM, Videnovic A, Benatar M, Cahill C, Kluger BM, Goldman M
• The importance of early immunotherapy in patients with faciobrachial dystonic seizures.
  Brain : a journal of neurology 2018 Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR, Faciobrachial Dystonic …
• Harnessing electronic medical records to advance research on multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2018 Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, …
• Pleocytosis is not fully responsible for low CSF glucose in meningitis.
  Neurology(R) neuroimmunology & neuroinflammation 2017 Baud MO, Vitt JR, Robbins NM, Wabl R, Wilson MR, Chow FC, Gelfand JM, Josephson SA, Miller S
• Demystifying Neurosarcoidosis and Informing Prognosis.
  JAMA neurology 2017 Gelfand JM
• Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.
  Neurology 2017 Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ…
• Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
  Lancet (London, England) 2017 Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR
• Focal cerebral β-amyloid angiopathy: A distinct clinicopathologic presentation.
  Neurology. Clinical practice 2017 Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT
• Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.
  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2017 Gelfand JM, Cree BAC, Hauser SL
• Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
  Journal of the neurological sciences 2017 Tremblay MA, Villanueva-Meyer JE, Cha S, Tihan T, Gelfand JM
• Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.
  Lung 2017 Benn BS, Lehman Z, Kidd SA, Ho M, Sun S, Ramstein J, Arger NK, Nguyen CP, Su R, Gomez A, Gelfand JM, Koth LL
• Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.
  Science translational medicine 2017 Ward ME, Chen R, Huang HY, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV, Leslie S, Seeley WW, Miller BL, Bigio E,…
• Risk of Multiple Sclerosis After a Clinically Isolated Syndrome: From Magnetic Resonance Imaging to Oligoclonal Bands to Activated T Cells.
  JAMA neurology 2017 Gelfand JM
• Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults.
  Neurobiology of aging 2016 Casaletto KB, Ward ME, Baker NS, Bettcher BM, Gelfand JM, Li Y, Chen R, Dutt S, Miller B, Kramer JH, Green AJ
• Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.
  Journal of neurology 2016 Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM
• Long-term evolution of multiple sclerosis disability in the treatment era.
  Annals of neurology 2016 University of California, San Francisco MS-EPIC Team:, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von …
• Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis.
  Annals of the rheumatic diseases 2016 Miloslavsky EM, Naden RP, Bijlsma JW, Brogan PA, Brown ES, Brunetta P, Buttgereit F, Choi HK, DiCaire JF, Gelfand JM, Heaney LG, Lightstone L, Lu N, Murrell DF, Petri M, Rosenbaum JT, Saag KS, Urowitz…
• Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
  Journal of neurology 2016 Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BM, Petzold A, Green AJ
• Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
  PloS one 2016 Block VA, Pitsch E, Tahir P, Cree BA, Allen DD, Gelfand JM
• Development of a Diagnostic Decision Tree for Rapidly Progressive Dementia (P5.182).
  Neurology 2016 Jeffrey Gelfand, Carolyn Fredericks, Natasha Rabinowitz, Katherine Rankin, Christopher Hess, Matteo Paoletti, Joseph Higgins, Gary Williams, Bruce Miller, Howard Rosen, Michael Geschwind
• A clinical approach to diagnosis of autoimmune encephalitis.
  The Lancet. Neurology 2016 Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, …
• The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum.
  Neurology(R) neuroimmunology & neuroinflammation 2016 Schubert RD, Wood M, Levin MH, Perry A, Gelfand JM
• One Brain, Two Specialties, Converging Mechanisms: Neuronal Autoantibodies as a Rare Cause of Postpartum Psychosis.
  The American journal of psychiatry 2015 Gelfand JM
• Diagnosing Balamuthia mandrillaris Encephalitis With Metagenomic Deep Sequencing.
  Annals of neurology 2015 Wilson MR, Shanbhag NM, Reid MJ, Singhal NS, Gelfand JM, Sample HA, Benkli B, O'Donovan BD, Ali IK, Keating MK, Dunnebacke TH, Wood MD, Bollen A, DeRisi JL
• Neurosarcoidosis
  In: Samuels M, editor. Scientific American Neurology. 2015 Gelfand JM Stern BJ
• Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
  JAMA neurology 2015 Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA…
• Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.
  Neurology 2015 Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J
• Harrison's Principles of Internal Medicine. 19th Edition. Edited by Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, Joseph Loscalzo
  Chapter 29: Fatigue 2015 Gelfand, JM. Douglas, VC.
• Therapeutic management of severe relapses in multiple sclerosis.
  Current treatment options in neurology 2015 Bevan C, Gelfand JM
• Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge.
  JAMA neurology 2015 Gelfand JM, Genrich G, Green AJ, Tihan T, Cree BA
• Precision medicine in chronic disease management: The multiple sclerosis BioScreen.
  Annals of neurology 2014 Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-…
• Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
  Neurology(R) neuroimmunology & neuroinflammation 2014 Gelfand JM, Cotter J, Klingman J, Huang EJ, Cree BA
• Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
  JAMA neurology 2014 Naasan G, Irani SR, Bettcher BM, Geschwind MD, Gelfand JM
• Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.
  The Journal of experimental medicine 2014 Ward ME, Taubes A, Chen R, Miller BL, Sephton CF, Gelfand JM, Minami S, Boscardin J, Martens LH, Seeley WW, Yu G, Herz J, Filiano AJ, Arrant AE, Roberson ED, Kraft TW, Farese RV, Green A, Gan L
• Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
  Annals of neurology 2014 Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG
• Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.
  Annals of neurology 2014 Irani SR, Gelfand JM, Al-Diwani A, Vincent A
• Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.
  JAMA neurology 2014 Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD
• More than memory impairment in voltage-gated potassium channel complex encephalopathy.
  European journal of neurology 2014 Bettcher BM, Gelfand JM, Irani SR, Neuhaus J, Forner S, Hess CP, Geschwind MD
• The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
  Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2014 Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi…
• Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation.
  Handbook of clinical neurology 2014 Gelfand JM
• Microcystic inner nuclear layer abnormalities and neuromyelitis optica.
  JAMA neurology 2013 Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ
• Migraine and multiple sclerosis: Epidemiology and approach to treatment.
  Multiple sclerosis and related disorders 2013 Gelfand AA, Gelfand JM, Goadsby PJ
• Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.
  Annals of neurology 2012 Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J
• Fingolimod treatment in multiple sclerosis leads to increased macular volume.
  Neurology 2012 Nolan R, Gelfand JM, Green AJ
• Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
  The Lancet. Neurology 2012 Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA
• Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes.
  PloS one 2012 Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ
• Microcystic macular oedema in multiple sclerosis is associated with disease severity.
  Brain : a journal of neurology 2012 Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ
• Neurology Now
  Should I see a neurologist for sarcoidosis? 2012 Gelfand JM
• Color vision is strongly associated with retinal thinning in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2012 Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A
• Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review.
  Journal of child neurology 2012 Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ
• Vitamin D in African Americans with multiple sclerosis.
  Neurology 2011 Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ
• Heterogeneous patterns of tissue injury in NARP syndrome.
  Journal of neurology 2010 Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, Zhang Y, Zhang Q, Wong LJ, Roorda A, Green AJ
• Cardiac rupture after intravenous t-PA administration in acute ischemic stroke.
  Neurocritical care 2010 Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, Tihan T
• Cerebral perfusion-CT patterns following seizure.
  European journal of neurology 2009 Gelfand JM, Wintermark M, Josephson SA
• Speech-activated myoclonus masquerading as stuttering.
  Neurology 2009 Gelfand JM, Nelson AB, Fross RD, Glass GA